Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| United Therapeutics Corporation(UTHR) | 2,858,888 | 2,858,888 | 0 | $656.74M | $910.70M | 12.13% | +$253.96M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,944,444 | 2,055,555 | +111,111 | $519.24M | $575.88M | 7.67% | +$56.64M |
| Ascendis Pharma A/SADR(ASND) | 3,966,666 | 4,196,661 | +229,995 | $599.64M | $572.34M | 7.62% | -$27.30M |
| argenx SEADR(ARGX) | 1,238,467 | 1,238,467 | 0 | $487.61M | $532.59M | 7.09% | +$44.98M |
| Sarepta Therapeutics, Inc.(SRPT) | 4,344,444 | 3,000,000 | -1,344,444 | $562.43M | $474.00M | 6.31% | -$88.43M |
| Krystal Biotech, Inc.(KRYS) | 2,555,555 | 2,433,000 | -122,555 | $454.71M | $446.80M | 5.95% | -$7.91M |
| Apellis Pharmaceuticals Inc. COM | 11,111,111 | 11,111,111 | 0 | $653.11M | $426.22M | 5.68% | -$226.89M |
| BioMarin Pharmaceutical Inc.(BMRN) | 4,365,000 | 4,557,416 | +192,416 | $381.24M | $375.21M | 5.00% | -$6.03M |
| Cerevel Therapeutics Hldng | 7,555,555 | 7,539,547 | -16,008 | $319.37M | $308.29M | 4.11% | -$11.08M |
| Spdr Series Trust - S&p BiotechETF ST STR SP BIOT | 4,300,000 | 3,035,000 | -1,265,000 | $408.03M | $281.37M | 3.75% | -$126.65M |
| Amicus Therapeutics Inc. COM | 27,400,000 | 27,400,000 | 0 | $322.77M | $271.81M | 3.62% | -$50.96M |
| Avidity Biosciences Inc | 5,825,000 | 6,505,000 | +680,000 | $148.65M | $265.73M | 3.54% | +$117.08M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 8,555,555 | 8,888,888 | +333,333 | $244.69M | $231.02M | 3.08% | -$13.67M |
| Xenon Pharmaceuticals Inc.(XENE) | 5,666,666 | 5,666,666 | 0 | $243.95M | $220.94M | 2.94% | -$23.01M |
| Intra-Cellular Therapies Inc | 2,475,000 | 3,000,000 | +525,000 | $171.27M | $205.47M | 2.74% | +$34.20M |
| Vera Therapeutics, Inc.(VERA) | 5,265,000 | 4,309,590 | -955,410 | $227.03M | $155.92M | 2.08% | -$71.11M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 2,580,000 | 2,770,000 | +190,000 | $129.59M | $121.80M | 1.62% | -$7.80M |
| Kymera Therapeutics, Inc.(KYMR) | 3,888,888 | 3,888,888 | 0 | $156.33M | $116.08M | 1.55% | -$40.25M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 300,000 | 400,000 | +100,000 | $44.84M | $97.20M | 1.29% | +$52.37M |
| Iovance Biotherapeutics, Inc.(IOVA) | 11,700,000 | 11,700,000 | 0 | $173.39M | $93.83M | 1.25% | -$79.56M |
| Soleno Therapeutics Inc | 1,625,000 | 2,091,666 | +466,666 | $69.55M | $85.34M | 1.14% | +$15.79M |
| Merus N V | 888,888 | 1,355,000 | +466,112 | $40.03M | $80.18M | 1.07% | +$40.15M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 4,222,222 | 3,888,437 | -333,785 | $100.49M | $79.83M | 1.06% | -$20.66M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 13,050,000 | 12,570,000 | -480,000 | $66.29M | $77.68M | 1.03% | +$11.39M |
| Kura Oncology, Inc.(KURA) | 3,850,000 | 3,541,505 | -308,495 | $82.12M | $72.92M | 0.97% | -$9.20M |
| Ocular Therapeutix, Inc.(OCUL) | 7,148,936 | 8,060,000 | +911,064 | $65.06M | $55.13M | 0.73% | -$9.92M |
| MannKind Corporation(MNKD) | 9,000,000 | 8,759,524 | -240,476 | $40.77M | $45.72M | 0.61% | +$4.95M |
| Vaxcyte, Inc.(PCVX) | 575,000 | 575,000 | 0 | $39.28M | $43.42M | 0.58% | +$4.14M |
| Spyre Therapeutics, Inc.(SYRE) | 1,839,138 | 1,839,138 | 0 | $69.76M | $43.24M | 0.58% | -$26.52M |
| Autolus Therapeutics plcADR(AUTL) | 12,345,678 | 12,345,678 | 0 | $78.77M | $42.96M | 0.57% | -$35.80M |
| Taysha Gene Therapies, Inc.(TSHA) | 18,650,000 | 18,650,000 | 0 | $53.53M | $41.78M | 0.56% | -$11.75M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 830,000 | 830,000 | 0 | $38.75M | $34.11M | 0.45% | -$4.64M |
| Verrica Pharmaceuticals Inc.(VRCA) | 3,999,999 | 3,999,999 | 0 | $23.68M | $29.16M | 0.39% | +$5.48M |
| Tourmaline Bio Inc | 2,222,222 | 2,222,222 | 0 | $50.89M | $28.58M | 0.38% | -$22.31M |
| CG Oncology, Inc.(CGON) | 700,000 | 700,000 | 0 | $30.73M | $22.10M | 0.29% | -$8.63M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,535,000 | 4,535,000 | 0 | $31.97M | $16.96M | 0.23% | -$15.01M |
| Bicycle Therapeutics PlcADR | 0 | 700,000 | +700,000 | $0 | $14.17M | 0.19% | +$14.17M |
| Whitehawk Therapeutics, Inc.(WHWK) | 2,849,402 | 2,849,402 | 0 | $6.67M | $4.16M | 0.06% | -$2.51M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 115,751 | +115,751 | $0 | $4.08M | 0.05% | +$4.08M |
| Adverum Biotechnologies Inc | 416,666 | 416,666 | 0 | $5.89M | $2.86M | 0.04% | -$3.03M |
| Neurogene Inc.(NGNE) | 0 | 22,029 | +22,029 | $0 | $801.6K | 0.01% | +$801.6K |
| Alpine Immune Sciences Inc | 5,775,000 | 0 | -5,775,000 | $228.92M | $0 | — | -$228.92M |
| CRISPR Therapeutics AG(CRSP) | 419,580 | 0 | -419,580 | $28.60M | $0 | — | -$28.60M |
| Kyverna Therapeutics, Inc.(KYTX) | 475,000 | 0 | -475,000 | $11.80M | $0 | — | -$11.80M |
| MacroGenics, Inc.(MGNX) | 6,150,000 | 0 | -6,150,000 | $90.53M | $0 | — | -$90.53M |
| Marinus Pharmaceuticals Inc | 4,140,607 | 0 | -4,140,607 | $37.43M | $0 | — | -$37.43M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,260,900 | 0 | -1,260,900 | $33.97M | $0 | — | -$33.97M |
| Roivant Sciences Ltd.(ROIV) | 4,651,162 | 0 | -4,651,162 | $49.02M | $0 | — | -$49.02M |
| Viking Therapeutics, Inc.(VKTX) | 3,590,000 | 0 | -3,590,000 | $294.38M | $0 | — | -$294.38M |